|
|
|
Volumn 274, Issue 1, 1995, Pages 329-336
|
|
7-{4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)- quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 [3 [4 (2,3 DIMETHYLPHENYL) 1 PIPERAZINYL]PROPOXY] 2(1H) QUINOLINONE;
APOMORPHINE;
ARIPIPRAZOLE;
AUTORECEPTOR;
DOPAMINE 2 RECEPTOR;
GAMMA BUTYROLACTONE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
RESERPINE;
TYROSINE 3 MONOOXYGENASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BEHAVIOR DISORDER;
CORPUS STRIATUM;
ENZYME INHIBITION;
FRONTAL CORTEX;
LIMBIC CORTEX;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PSYCHOSIS;
STEREOTYPY;
4-BUTYROLACTONE;
ANIMAL;
ANTIPSYCHOTIC AGENTS;
APOMORPHINE;
CATALEPSY;
CORPUS STRIATUM;
DIHYDROXYPHENYLALANINE;
DOPAMINE AGONISTS;
DRUG INTERACTIONS;
MALE;
MICE;
MICE, INBRED ICR;
MOTOR ACTIVITY;
OXIDOPAMINE;
PIPERAZINES;
PRESYNAPTIC TERMINALS;
QUINOLONES;
RADIOLIGAND ASSAY;
RATS;
RECEPTORS, DOPAMINE D2;
RESERPINE;
SPIPERONE;
STEREOTYPED BEHAVIOR;
SYNAPSES;
TRITIUM;
|
|
EID: 0029023002
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (299)
|
|
References (0)
|
